MIM
SBBP

Monashee Investment Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Monashee Investment Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400,000
Closed -$840K – 349
2020
Q3 		$840K Buy
+400,000
New +$1.35M 0.18% 104

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Monashee Investment Management's SBBP Position: Q4 2020 in Review

Monashee Investment Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 400,000 shares — an estimated $840K sold.

Monashee Investment Management first reported a position in SBBP in Q3 2020 and held it in 1 quarter. The position peaked at $840K in Q3 2020. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

  • Monashee Investment Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
  • Monashee Investment Management sold 400,000 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $840K.
  • Monashee Investment Management first reported a position in Strongbridge Biopharma plc. in Q3 2020 and held it in 1 quarter.
  • Monashee Investment Management's Strongbridge Biopharma plc. position peaked at $840K in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.